Maker Halts Distribution of Generic Zantac Due to Possible Carcinogen
Preliminary tests revealed low levels of the nitrosamine impurity NDMA in some ranitidine products
House Speaker Unveils Plan to Lower Drug Costs
Plan would allow Medicare to negotiate prices for high-cost drugs
Polypill Strategy Promising in Socioeconomically Vulnerable
Greater reductions in systolic blood pressure, LDL cholesterol levels with polypill in minority population
Seniors Should Undergo Annual Cognitive Health Assessment
After MCI diagnosis, patients should be counseled on treatment options; support needed for partners
Pharmacist in ED Cuts Time to Tx to Reverse Anticoagulation
Time to 4F-PCC shorter for patients who have life-threatening bleeding, need urgent procedures
Many Older Patients With AML Not Receiving Active Treatment
No active treatment more likely with older age, lower household income, unmarried status, comorbidities
Aortic, Mitral Regurgitation Risk Up With Fluoroquinolone Use
Risk significantly increased for current use and recent use, but not past use within 61 to 365 days
Patients With Rheumatic Disease Often Have Trouble Accessing Care
Access issues include getting specialty appointments and affording treatment
Combo Antithrombotic Therapy Increases Bleeding Risk
Greatest risk seen in first year of treatment, but benefits of combo therapy continue after one year
Off-Label Ordering of Systemic Drugs Up for Children
Over time, off-label orders have increased for antihistamines, several psychotropics
